Re: Zenith Corporate Update

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Corporate Update

in response to

Re: Zenith Corporate Update

SanFrancisco99

posted on Dec 05, 2016 01:24PM

SanFran,

As of today Resverlogix, but not Zenith, have published details about their webcast. So we should be expecting, at minimum, a news release for the Zenith webcast similar to the one from Resverlogix. Of course, there might be something else wrapping into that news release. We'll have to wait and see.